These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 21697511)

  • 1. Cyclin-dependent kinase subunit (Cks) 1 or Cks2 overexpression overrides the DNA damage response barrier triggered by activated oncoproteins.
    Liberal V; Martinsson-Ahlzén HS; Liberal J; Spruck CH; Widschwendter M; McGowan CH; Reed SI
    Proc Natl Acad Sci U S A; 2012 Feb; 109(8):2754-9. PubMed ID: 21697511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CKS Proteins Promote Checkpoint Recovery by Stimulating Phosphorylation of Treslin.
    Mu R; Tat J; Zamudio R; Zhang Y; Yates JR; Kumagai A; Dunphy WG; Reed SI
    Mol Cell Biol; 2017 Oct; 37(20):. PubMed ID: 28739856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclin-dependent kinase-associated proteins Cks1 and Cks2 are essential during early embryogenesis and for cell cycle progression in somatic cells.
    Martinsson-Ahlzén HS; Liberal V; Grünenfelder B; Chaves SR; Spruck CH; Reed SI
    Mol Cell Biol; 2008 Sep; 28(18):5698-709. PubMed ID: 18625720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CKS proteins protect mitochondrial genome integrity by interacting with mitochondrial single-stranded DNA-binding protein.
    Radulovic M; Crane E; Crawford M; Godovac-Zimmermann J; Yu VP
    Mol Cell Proteomics; 2010 Jan; 9(1):145-52. PubMed ID: 19786724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aberrant expression of Cks1 and Cks2 contributes to prostate tumorigenesis by promoting proliferation and inhibiting programmed cell death.
    Lan Y; Zhang Y; Wang J; Lin C; Ittmann MM; Wang F
    Int J Cancer; 2008 Aug; 123(3):543-51. PubMed ID: 18498131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical significance and expression of cyclin kinase subunits 1 and 2 in hepatocellular carcinoma.
    Shen DY; Fang ZX; You P; Liu PG; Wang F; Huang CL; Yao XB; Chen ZX; Zhang ZY
    Liver Int; 2010 Jan; 30(1):119-25. PubMed ID: 19845855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CKS protein overexpression renders tumors susceptible to a chemotherapeutic strategy that protects normal tissues.
    Tat J; Loriot C; Henze M; Spruck C; Felding BH; Reed SI
    Oncotarget; 2017 Dec; 8(70):114911-114923. PubMed ID: 29383129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cks overexpression enhances chemotherapeutic efficacy by overriding DNA damage checkpoints.
    del Rincón SV; Widschwendter M; Sun D; Ekholm-Reed S; Tat J; Teixeira LK; Ellederova Z; Grolieres E; Reed SI; Spruck C
    Oncogene; 2015 Apr; 34(15):1961-7. PubMed ID: 24858038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical significance of overexpressed cyclin-dependent kinase subunits 1 and 2 in esophageal carcinoma.
    Wang JJ; Fang ZX; Ye HM; You P; Cai MJ; Duan HB; Wang F; Zhang ZY
    Dis Esophagus; 2013; 26(7):729-36. PubMed ID: 23301842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The CDK subunit CKS2 counteracts CKS1 to control cyclin A/CDK2 activity in maintaining replicative fidelity and neurodevelopment.
    Frontini M; Kukalev A; Leo E; Ng YM; Cervantes M; Cheng CW; Holic R; Dormann D; Tse E; Pommier Y; Yu V
    Dev Cell; 2012 Aug; 23(2):356-70. PubMed ID: 22898779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinicopathological and biological significance of CDC28 protein kinase regulatory subunit 2 overexpression in human gastric cancer.
    Tanaka F; Matsuzaki S; Mimori K; Kita Y; Inoue H; Mori M
    Int J Oncol; 2011 Aug; 39(2):361-72. PubMed ID: 21617860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell cycle. Checking two steps.
    Kastan MB
    Nature; 2001 Apr; 410(6830):766-7. PubMed ID: 11298430
    [No Abstract]   [Full Text] [Related]  

  • 13. Oncogenic potential of cyclin kinase subunit-2 in cholangiocarcinoma.
    Shen DY; Zhan YH; Wang QM; Rui G; Zhang ZM
    Liver Int; 2013 Jan; 33(1):137-48. PubMed ID: 23121546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The expression of the ubiquitin ligase subunit Cks1 in human breast cancer.
    Slotky M; Shapira M; Ben-Izhak O; Linn S; Futerman B; Tsalic M; Hershko DD
    Breast Cancer Res; 2005; 7(5):R737-44. PubMed ID: 16168119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reconstitution of an ATM-dependent checkpoint that inhibits chromosomal DNA replication following DNA damage.
    Costanzo V; Robertson K; Ying CY; Kim E; Avvedimento E; Gottesman M; Grieco D; Gautier J
    Mol Cell; 2000 Sep; 6(3):649-59. PubMed ID: 11030344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. v-Jun overrides the mitogen dependence of S-phase entry by deregulating retinoblastoma protein phosphorylation and E2F-pocket protein interactions as a consequence of enhanced cyclin E-cdk2 catalytic activity.
    Clark W; Black EJ; MacLaren A; Kruse U; LaThangue N; Vogt PK; Gillespie DA
    Mol Cell Biol; 2000 Apr; 20(7):2529-42. PubMed ID: 10713176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of cyclin-dependent kinase subunit 1 (Cks1) is regulated during the cell cycle by a CDE/CHR tandem element and is downregulated by p53 but not by p63 or p73.
    Rother K; Li YY; Tschöp K; Kirschner R; Müller GA; Mössner J; Engeland K
    Cell Cycle; 2007 Apr; 6(7):853-62. PubMed ID: 17377499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of cyclin-dependent kinase 2 by the Chk1-Cdc25A pathway during the S-phase checkpoint activated by fludarabine: dysregulation by 7-hydroxystaurosporine.
    Sampath D; Shi Z; Plunkett W
    Mol Pharmacol; 2002 Sep; 62(3):680-8. PubMed ID: 12181445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluoxetine mediates G0/G1 arrest by inducing functional inhibition of cyclin dependent kinase subunit (CKS)1.
    Krishnan A; Hariharan R; Nair SA; Pillai MR
    Biochem Pharmacol; 2008 May; 75(10):1924-34. PubMed ID: 18371935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The DNA damage-dependent intra-S phase checkpoint is regulated by parallel pathways.
    Falck J; Petrini JH; Williams BR; Lukas J; Bartek J
    Nat Genet; 2002 Mar; 30(3):290-4. PubMed ID: 11850621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.